{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["N/A"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001008800"],"sample_count":["603"],"description":["EGA dataset EGAD00001008800"],"repository":["EGA"],"title":["low pass WGS of patient from the CN300 cohort"],"additional_accession":[]},"is_claimable":false,"name":"7a528f9b-17a4-406c-9542-1a49d3e676f5 - samples","description":"We copy number profiled 688 tumor regions from 300 patients presenting with advanced prostate cancer and prospectively followed-up (median, 7 years) in the control group of the STAMPEDE trial. Patients were categorised into four metastatic states, namely high-risk non-metastatic (with or without local lymph node involvement) or metastatic (low or high volume).","dates":{"updated":"2022-06-02 10:22:43"},"accession":"EGAD00001008800","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAC00001002659","EGAS00001006251"]}}